Evidence map›Paper›PMID 38489196›Full record

ArticleJournal of neuromuscular diseases2024

Improving Diagnostic Precision: Phenotype-Driven Analysis Uncovers a Maternal Mosaicism in an Individual with RYR1-Congenital Myopathy.

Berta Estévez-Arias, Leslie Matalonga, Loreto Martorell, Anna Codina, Carlos Ortez, Laura Carrera-García, Jessica Expósito-Escudero, Delia Yubero, Janet Hoenicka, Cristina Jou and 6 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Journal of neuromuscular diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 4 countries.

Berta Estévez-AriasNeuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
Leslie MatalongaCentro Nacional Análisis Genómico (CNAG), Barcelona, Spain.
Loreto MartorellCenter for Biomedical Research Network on Rare Diseases (CIBERER), ISCIII, Spain.
Anna CodinaApplied Research in Neuromuscular Diseases, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
Carlos OrtezNeuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
Laura Carrera-GarcíaNeuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
Jessica Expósito-EscuderoNeuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
Delia YuberoCenter for Biomedical Research Network on Rare Diseases (CIBERER), ISCIII, Spain.
Janet HoenickaLaboratory of Neurogenetics and Molecular Medicine - IPER, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
Cristina JouCenter for Biomedical Research Network on Rare Diseases (CIBERER), ISCIII, Spain.
Francesc PalauLaboratory of Neurogenetics and Molecular Medicine - IPER, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
Sergi BeltranCentro Nacional Análisis Genómico (CNAG), Barcelona, Spain.
Hanns LochmüllerCentro Nacional Análisis Genómico (CNAG), Barcelona, Spain.
Ana TöpfThe John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
Andrés NascimentoNeuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
Daniel Natera-de BenitoNeuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
Hospital Sant Joan de Déu Barcelona · ESCentro Nacional de Análisis Genómico · ESChildren's Hospital of Eastern Ontario · CANewcastle upon Tyne Hospitals NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congenital myopathies (CMs) are rare genetic disorders for which the diagnostic yield does not typically exceed 60% . We performed deep phenotyping, histopathological studies, clinical exome and trio genome sequencing and a phenotype-driven analysis of the genomic data, that led to the molecular diagnosis in a child with CM. We identified a heterozygous variant in RYR1 in the affected child, inherited from her asymptomatic mother. Given the alignment of the clinical and histopathological phenotype with RYR1-CM, we considered the potential existence of a missing second variant in trans in the proband, but also hypothesized that the variant might be mosaic in the mother, as subsequently demonstrated. Our study is an example of how heterozygous variants inherited from asymptomatic parents are frequently dismissed. When the genotype-phenotype correlation is strong, it is recommended to consider a parental mosaicism.

Indexed as

MosaicismPhenotypeRyanodine Receptor Calcium Release ChannelChild, PreschoolGenetic Association StudiesHumansMaleMyotonia CongenitaRyanodine Receptor Calcium Release ChannelRYR1 protein, humanCongenital myopathy,genome sequencingmosaicismRYR1

Identifiers

PMID38489196
PMCPMC11091619
OpenAlexW4392698105

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.